Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib for Occult Tumor Cells in High Risk Early Stage Breast Cancer
NCT00824538Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Feb 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sunitinib in breast cancer, sponsored by University of California, San Francisco. Started Feb 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00824538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824538.